Scisparc Ltd stock is traded at $0.3531, with a volume of 50,562. It is down -0.62% in the last 24 hours and down -91.04% over the past month. SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Previous Close:
$0.3553
Open:
$0.3588
24h Volume:
50,562
Relative Volume:
0.31
Market Cap:
$205.14K
Revenue:
$856.00K
Net Income/Loss:
-$12.56M
P/E Ratio:
-
EPS:
-$231.49
Net Cash Flow:
-$4.14M
1W Performance:
-15.65%
1M Performance:
-91.04%
6M Performance:
-92.97%
1Y Performance:
-98.47%
1-Day Range:
$0.3452$0.37
1-Week Range:
$0.3452$0.4424
52-Week Range:
$0.3452$29.88
Scisparc Ltd Stock (SPRC) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS